DE3521303A1 - 4,5,6,7-tetrahydroimidazo(4,5- c)pyridinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten - Google Patents

4,5,6,7-tetrahydroimidazo(4,5- c)pyridinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Info

Publication number
DE3521303A1
DE3521303A1 DE19853521303 DE3521303A DE3521303A1 DE 3521303 A1 DE3521303 A1 DE 3521303A1 DE 19853521303 DE19853521303 DE 19853521303 DE 3521303 A DE3521303 A DE 3521303A DE 3521303 A1 DE3521303 A1 DE 3521303A1
Authority
DE
Germany
Prior art keywords
group
compound
formula
hydrogen
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19853521303
Other languages
German (de)
English (en)
Inventor
Roberto De Castiglione
Roberto Cimaschi
Ugo Arese Mailand/Milano Scarponi
Antonietta Mailand/Milano Verini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of DE3521303A1 publication Critical patent/DE3521303A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE19853521303 1985-01-22 1985-06-13 4,5,6,7-tetrahydroimidazo(4,5- c)pyridinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten Withdrawn DE3521303A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858501542A GB8501542D0 (en) 1985-01-22 1985-01-22 4 5 6 7-tetrahydro-imidazo(4 5-clpyridine derivatives

Publications (1)

Publication Number Publication Date
DE3521303A1 true DE3521303A1 (de) 1985-10-31

Family

ID=10573211

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19853521303 Withdrawn DE3521303A1 (de) 1985-01-22 1985-06-13 4,5,6,7-tetrahydroimidazo(4,5- c)pyridinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Country Status (4)

Country Link
JP (1) JPS61167687A (fr)
BE (1) BE902611A (fr)
DE (1) DE3521303A1 (fr)
GB (2) GB8501542D0 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0245637A1 (fr) * 1986-04-01 1987-11-19 Warner-Lambert Company Dérivés de la 4,5,6,7-tétrahydro-1H-imidazo[4,5-c]pyridine et leurs analogues ayant une activité antihypertensive
US7071355B2 (en) 2002-12-23 2006-07-04 4 Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
US7365094B2 (en) 2002-12-23 2008-04-29 4Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816463A (en) * 1986-04-01 1989-03-28 Warner-Lambert Company Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity
JP2002534511A (ja) 1999-01-18 2002-10-15 ノボ ノルディスク アクティーゼルスカブ 置換型イミダゾール、それらの調製及び使用
US6908926B1 (en) 1999-04-16 2005-06-21 Novo Nordisk A/S Substituted imidazoles, their preparation and use
WO2002038153A1 (fr) * 2000-11-09 2002-05-16 Biovitrum Ab Nouvelle utilisation de derives de 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
US7247736B2 (en) 2002-12-23 2007-07-24 4Sc Ag Method of identifying inhibitors of DHODH
ES2381890T3 (es) * 2003-12-22 2012-06-01 K.U.Leuven Research & Development Compuesto de imidazo[4,5-c]piridina y métodos de tratamiento antiviral
CN101027303A (zh) 2004-07-27 2007-08-29 吉里德科学公司 咪唑并[4，5－d]嘧啶类、其应用和制备方法
JP2008524335A (ja) 2004-12-21 2008-07-10 ギリアド サイエンシズ， インコーポレイテッド イミダゾ［４，５−ｃ］ピリジン化合物および抗ウイルス処置法
ATE454384T1 (de) 2006-07-07 2010-01-15 Gilead Sciences Inc Neue pyridazinverbindung und ihre verwendung
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
US20180200233A1 (en) * 2015-07-16 2018-07-19 Loma Linda University Compositions for preventing cancers associated with human papilloma viruses
US10858366B2 (en) * 2016-03-08 2020-12-08 Novartis Ag Tricyclic compounds useful to treat orthomyxovirus infections
JOP20170169A1 (ar) 2016-08-29 2019-01-30 Novartis Ag مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو
UA126253C2 (uk) 2018-02-28 2022-09-07 Новартіс Аг ПОХІДНІ 10-(ДИ(ФЕНІЛ)МЕТИЛ)-4-ГІДРОКСИ-8,9,9а,10-ТЕТРАГІДРО-7H-ПІРОЛО[1',2':4,5]ПІРАЗИНО[1,2-b]ПІРИДАЗИН-3,5-ДІОНУ ЯК ІНГІБІТОРИ РЕПЛІКАЦІЇ ОРТОМІКСОВІРУСУ ДЛЯ ЛІКУВАННЯ ГРИПУ

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0245637A1 (fr) * 1986-04-01 1987-11-19 Warner-Lambert Company Dérivés de la 4,5,6,7-tétrahydro-1H-imidazo[4,5-c]pyridine et leurs analogues ayant une activité antihypertensive
US7071355B2 (en) 2002-12-23 2006-07-04 4 Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
US7365094B2 (en) 2002-12-23 2008-04-29 4Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents

Also Published As

Publication number Publication date
JPS61167687A (ja) 1986-07-29
GB2158440B (en) 1988-06-02
GB8501542D0 (en) 1985-02-20
GB2158440A (en) 1985-11-13
GB8514278D0 (en) 1985-07-10
BE902611A (fr) 1985-09-30

Similar Documents

Publication Publication Date Title
DE3521303A1 (de) 4,5,6,7-tetrahydroimidazo(4,5- c)pyridinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
EP0079022B1 (fr) Dérivés de l'acide cis, endo-2-azabicyclo-(3.3.0)-octane-3-carboxylique, procédé pour leur préparation, medicaments les contenant et leur application
AT390732B (de) Pharmazeutika enthaltend pyrazole
DE2255172A1 (de) Imidazotriazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
CH645625A5 (de) Benzoesaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel.
DE69722858T2 (de) Intimale verdickungsinhibitoren
EP0047923B1 (fr) Dérivés de l'isoquinoléine, leurs procédés de préparation et compositions pharmaceutiques les contenant
CH671958A5 (fr)
DE10046029A1 (de) Indazole
DE68925270T2 (de) Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidinderivate und diese enthaltende Arzneimittel
DE3031791C2 (fr)
DE2163601A1 (de) Arzneimittel mit einem Gehalt an (3,5,3,5-Tetraoxo)-1,2-dipiperazinoalkanverbindungen und Verfahren zur Herstellung der Verbindungen
DE2802630A1 (de) 6-ethoxy-1,2-dihydro-2,2,4-trimethylchinolinderivate und verfahren zu ihrer herstellung
EP0431371B1 (fr) 3-Aminopyrroles, procédé pour leur préparation et leur utilisation comme anticonvulsifs
DD147110A5 (de) Verfahren zur herstellung von 9-eckige klammer auf 3-(3.5-cis-dimethylpiperazino)-propyl eckige klammer zu-carbazol und dessen salzen
DE2804519C2 (fr)
DE3049959C2 (fr)
EP0170861B1 (fr) Composés d'aminocarbonylméthoxy-3-phényl-5-pyrazol, procédé de leur préparation et les compositions pharmaceutiques les contenant
DE2535599C2 (de) Substituierte Zimtsäureamide, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten
DE69326111T2 (de) Hydantoinderivate, deren Salze und diese enthaltende Maillard-Reaktionsinhibitoren
DE3014813A1 (de) 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesaeure-derivate
EP0621037A1 (fr) Composés pyrido-pyrimidinediones, leur préparation et leur utilisation pharmaceutique
DD247448A5 (de) Verfahren zur herstellung neuer chinolinderivate
DE2305514A1 (de) Verfahren zur herstellung von lysergsaeureamiden und dihydrolysergsaeureamiden sowie lysergsaeureamide und dihydrolysergsaeureamide und ihre verwendung
DE69624236T2 (de) Ausgewählte lösliche ester von indolcarbazolen die hydroxyl enthalten

Legal Events

Date Code Title Description
OAV Applicant agreed to the publication of the unexamined application as to paragraph 31 lit. 2 z1
8141 Disposal/no request for examination